HealthBeacon shortlisted for Most Valuable Patient Initiative

HealthBeacon is shortlisted for the eyeforpharma Award, in the Most Valuable Patient Initiative category.

HealthBeacon was selected by a judging panel of pharma industry experts, patients and customers as a finalist. HealthBeacon will be represented at the award presentation by CEO, Jim Joyce. HealthBeacon will present their innovative technology to the judging panel on March 12th. Winners will be announced on 13th of March in Barcelona at eyeforpharma Barcelona in front of industry leaders, patients and other stakeholders.

About eyeforpharma awards

The eyeforpharma awards celebrate positive progress towards value for patients and customers and recognizes those in the pharmaceutical industry that are driving pharma forwards.

We celebrate those who aren’t just chasing higher short-term profits, but who are investing in better customer innovation, value and outcomes leading to longer-term success.

This is part of eyeforpharma’s mission to make the pharmaceutical industry more open and valued, which means these awards are a literal translation of why we exist. It is our responsibility to shine a light on where pharma does well, to inspire others into similar or better action.

About HealthBeacon

HealthBeacon is a Digital Therapeutics company that develops smart tools for managing medication. HealthBeacon has developed an injectable medication management system that tightly monitors patients digitally, keeps them adherent to their prescription and leverages real time data to drive clinical intervention. This system has been clinically reviewed, validated by the pharmaceutical industry and has been integrated into patient care programs throughout North America and Europe, delivering valuable data to both the patient and their clinical team.

Follow us on Twitter @HealthBeaconInc

Leave a Reply